Sweden

One of the shareholders in EQT, the Swedish private equity firm, has provided a rare liquidity event in the stock, which has rocketed more than 326% since its flotation in September 2019.

Swedish house selling platform Hemnet opened on Monday the books for its IPO on the Nasdaq Stockholm. Sources close to the deal said that the transaction was proving popular and expected it to price at a premium to listed competitors like the UK's Rightmove.

A handful of borrowers are circling the Nordic markets with an eye to printing after the end of first quarter results. But the looming blackouts have not deterred every type of credit from tapping the market as a range of corporate, covered bond and financial issuers placed paper this week.

Trustly, a Swedish payments company that allows people to transfer money directly from their bank accounts to make payments, has launched an IPO on Nasdaq Stockholm.

Lansforsakringar Bank (LF Bank) enjoyed the sole attention of the market on Thursday as it placed the day's only senior bond in euros. With market conditions constructive, bankers expect more esoteric names could follow.

Hemnet, the Swedish online property marketplace, has launched the marketing process for an IPO on the Nasdaq Stockholm exchange.

Kommuninvest plans to issue a debut social bond to fund its new social sustainability loans, which were launched on Tuesday after a successful pilot phase.

Swedish banks will have to maintain a countercyclical capital buffer worth 2% of their risk-weighted assets during normal times, according to new guidance from the nation’s Financial Supervisory Authority this week.

Embracer Group, the Swedish video games developer, has placed Skr7.6bn ($900m) of new shares with investors to finance its ongoing growth.

Cellink, the Swedish developer of 3D printing equipment for living cells, rose in trading on Friday morning after the company completed a Skr3bn ($350m) sale of new shares and convertible bonds to finance its acquisition of MatTek Corporation in the United States.

Swedish pharmaceutical company Oncopeptides has placed Skr1.1bn ($132m) of new shares to finance the commercialisation of its lead product candidate in the United States, and the development of other treatments.

Swedbank got stuck at initial price thoughts for a $750m three year preferred senior bond in the dollar market this week, having been forced to drop a longer dated leg from its offering.